US Lymphedema Treatment Market Analysis, Size, and Share by 2028

The US lymphedema treatment market size is expected to grow from US$ 5,185.98 million in 2022 to US$ 8,320.07 million by 2028; it is estimated to record a CAGR of 8.2% from 2023 to 2028.

The US lymphedema treatment market is segmented based on the condition type, treatment type, end user, and geography. The report offers insights and in-depth market analysis, emphasizing parameters such as drivers, trends, opportunities, and competitive landscape analysis of leading market players across various regions. It also includes analyses of the impact of the COVID-19 pandemic across major regions.

Market Insights

Increasing Healthcare Services and Lymphedema Management Programs Drive US Lymphedema Treatment Market Growth

The Intermountain Healthcare report states that treatment plans are designed for determining the stages and causes of the condition. For example, surgeons performed several reconstructive surgical interventions, including vascularized lymph node transfer, lymphovenous bypass, and a type of liposuction for reducing swelling. Additionally, the non-surgical techniques include complete decongestive therapy (CDT). An NCBI report states that the adoption of Complex Decongestive Physiotherapy (CDP) for treating lymphedema has slightly increased in Europe and the US. Several hospitals are equipped with beds that perform CDP on patients due to satisfactory medical coverage. For instance, the Trustees of the University of Pennsylvania report state that initial treatment of lymphedema comprises CDT. Therefore, Medicare covers physical and occupational therapists (PT/OT) visits with no financial limits on medically necessary services. The patients only will be responsible for 20% pay of the total treatment cost. Also, if the patient has a Medicare supplement, that 20% will be covered.

Customize This Report To Suit Your Requirement

You will get customization on any report - free of charge - including parts of this report, or country-level analysis, Excel Data pack, as well as avail great offers and discounts for start-ups & universities

Get FREE CUSTOMIZATION

US Lymphedema Treatment Market: Strategic Insights

• Get Top Key Market Trends of this report.
  This FREE sample will include data analysis, ranging from market trends to estimates and forecasts.

Free Sample PDF

New tests, coupled with technological advancements, play a critical role in controlling the prevalence of lymphedema cases among patients. For instance, in May 2021, Inspira Health offered the latest technology for the early detection of lymphedema, a common complication of breast cancer treatment. By utilizing the "ImpediMed SOZO Device," clinicians can detect small changes in the patient's fluid. By utilizing the SOZO device, fluid changes as small as 2.4 tablespoons can be detected, and the scan takes less than one minute to clinically detect lymphedema among patients. This technology is currently adopted and available at Inspira's Mullica Hill and Vineland cancer centers.

On the other hand, the Lymphedema Management Program provides services related to physical and occupational therapists that have been extensively trained in skilled treatment techniques for lymphedema management. For example, MedStar Health has developed a rehabilitation program based on therapists' training and working knowledge of current medical management of primary and secondary lymphedema with rehabilitative needs. Also, services by physical and occupational therapists are brought together for developing a personalized treatment plan for restoring the patient to the highest level of functioning. A major aim of such an innovative rehabilitation program is to educate and instruct patients about self-assist techniques for managing primary and secondary lymphedema independently.

Condition Type-Based Insights

Based on condition type, the US lymphedema treatment market is segmented into primary lymphedema and secondary lymphedema. The secondary lymphedema segment held a larger share of the market in 2022. The primary lymphedema segment is anticipated to register a higher CAGR in the market during the forecast period. Medical procedures involving radiation therapy or lymph node removal for the treatment of cancer, particularly breast cancer, can cause secondary lymphedema in most patients.

The US Lymphedema Treatment Market, by Condition Type – 2022–2028

Treatment Type-Based Insights

Based on treatment type, the US lymphedema treatment market is divided into laser therapy, compression devices and bandaging, drug therapy, physiological procedures, debulking procedures, and others. The physiological procedures segment is further segmented into lymphovenous anastomosis (LVA) and vascularized lymph node transfer (VLNT). Similarly, the debulking procedures segment is subdivided into surgical debulking, liposuction, and others. The compression devices and bandaging segment held the largest share of the market in 2022. The physiological procedure segment is anticipated to register the highest CAGR during the forecast period mainly due to the treatment availability through LVA and VLNT performed on lymphedema patients.

End User-Based Insights

Based on end user, the US lymphedema treatment market is divided into hospitals, clinics, clinical research organizations (CROs), and others (ambulatory care centers and primary care centers). The hospitals segment held the largest share of the market in 2022 and is anticipated to register the highest CAGR in the market during the forecast period due to the launch of several innovative products for maximum utilization in hospitals. In September 2020, Paul Hartmann partnered with Apollo Hospitals Group in India and West China Hospitals with a prime focus on the operation of wound care clinics and ambulances, medical training, and products and services. Such strategic steps provide companies to expand their product portfolio in the market. However, the clinics segment is expected to grow at the fastest rate during the coming years

The US lymphedema treatment market players adopt organic strategies such as product launch and expansion to expand their geographic footprint and product portfolios and meet the growing demands. Inorganic growth strategies adopted by market players allow them to expand their businesses and enhance their geographic presence. Additionally, these growth strategies help companies strengthen their clientele and enlarge their product portfolios.

• In October 2021, HARTMANN USA announced the immediate of TwoPress® 2 Lite. TwoPress® 2 Lite is an extension of our Two Layer Compression Systems. Along with TwoPress® 2, both systems offer simple and convenient application, which help boost clinician and patient confidence.
• In April 2023, AIROS Medical received FDA clearance to market new peristaltic pneumatic compression device, truncal garments for lymphedema treatment. The clearance also allows AIROS to provide larger compression therapy garments including lower truncal garments to treat abdominal swelling.
• In Dec 2020, Tactile Medical has received 510(k) clearance for two new indications for Flexitouch Plus system: phlebolymphedema and lipedema.

Company Profiles

• iHealth Labs Inc
• Oracle Corp
• Lantronix Inc.
• Infosys Ltd
• Digi International Inc.
• Cisco Systems Inc
• Medtronic Plc
• Koninklijke Philips NV
• GE HealthCare Technologies Inc
• Silicon & Software Systems Ltd.

US Lymphedema Treatment Market Regional Insights

The regional trends and factors influencing the US Lymphedema Treatment Market throughout the forecast period have been thoroughly explained by the analysts at The Insight Partners. This section also discusses US Lymphedema Treatment Market segments and geography across North America, Europe, Asia Pacific, Middle East and Africa, and South and Central America.

US Lymphedema Treatment Market Report Scope

US Lymphedema Treatment Market Players Density: Understanding Its Impact on Business Dynamics

The US Lymphedema Treatment Market is growing rapidly, driven by increasing end-user demand due to factors such as evolving consumer preferences, technological advancements, and greater awareness of the product's benefits. As demand rises, businesses are expanding their offerings, innovating to meet consumer needs, and capitalizing on emerging trends, which further fuels market growth.